BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34073553)

  • 1.
    Benesch MGK; Bursey SR; O'Connell AC; Ryan MG; Howard CL; Stockley CC; Mathieson A
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status.
    Mi EZ; Mi EZ; di Pietro M; O'Donovan M; Hardwick RH; Richardson S; Ziauddeen H; Fletcher PC; Caldas C; Tischkowitz M; Ragunath K; Fitzgerald RC
    Gastrointest Endosc; 2018 Feb; 87(2):408-418. PubMed ID: 28688938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study.
    Lee CYC; Olivier A; Honing J; Lydon AM; Richardson S; O'Donovan M; Tischkowitz M; Fitzgerald RC; di Pietro M
    Lancet Oncol; 2023 Jan; 24(1):107-116. PubMed ID: 36509094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with detection of hereditary diffuse gastric cancer on endoscopy in individuals with germline CDH1 mutations.
    Laszkowska M; Tang L; Vos E; King S; Salo-Mullen E; Magahis PT; Abate M; Catchings A; Zauber AG; Hahn AI; Schattner M; Coit D; Stadler ZK; Strong VE; Markowitz AJ
    Gastrointest Endosc; 2023 Sep; 98(3):326-336.e3. PubMed ID: 37094689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Random biopsies in patients harboring a CDH1 mutation: time to change the approach?
    Castro R; Lobo J; Pita I; Videira F; Pedro-Afonso L; Dinis-Ribeiro M; Brandão C
    Rev Esp Enferm Dig; 2020 May; 112(5):367-372. PubMed ID: 32338015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of E-cadherin Gene Mutations in Patients With Hereditary Diffuse Gastric Cancer Syndrome: A Systematic Review.
    Goud HK; Mehkari Z; Mohammed L; Javed M; Althwanay A; Ahsan F; Oliveri F; Rutkofsky IH
    Cureus; 2020 Sep; 12(9):e10406. PubMed ID: 33062523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
    Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
    Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroscopic surveillance with targeted biopsies compared with random biopsies in CDH1 mutation carriers.
    van Dieren JM; Kodach LL; den Hartog P; van der Kolk LE; Sikorska K; van Velthuysen MF; van Sandick JW; Koemans WJ; Snaebjornsson P; Cats A
    Endoscopy; 2020 Oct; 52(10):839-846. PubMed ID: 32408363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromoendoscopy in combination with random biopsies does not improve detection of gastric cancer foci in CDH1 mutation positive patients.
    Hüneburg R; Marwitz T; van Heteren P; Weismüller TJ; Trebicka J; Adam R; Aretz S; Perez Bouza A; Pantelis D; Kalff JC; Nattermann J; Strassburg CP
    Endosc Int Open; 2016 Dec; 4(12):E1305-E1310. PubMed ID: 27995193
    [No Abstract]   [Full Text] [Related]  

  • 10. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
    Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
    Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management.
    Shenoy S
    Cancer Manag Res; 2019; 11():10477-10486. PubMed ID: 31853199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.
    Hebbard PC; Macmillan A; Huntsman D; Kaurah P; Carneiro F; Wen X; Kwan A; Boone D; Bursey F; Green J; Fernandez B; Fontaine D; Wirtzfeld DA
    Ann Surg Oncol; 2009 Jul; 16(7):1890-5. PubMed ID: 19408054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
    Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
    Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk.
    Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of confocal endoscopic microscopy for detection of early-stage gastric cancer in hereditary diffuse gastric cancer (HDGC) syndrome.
    Ruff S; Curtin B; Quezado M; Heller T; Koh C; Steinberg SM; Connolly M; Hernandez JM; Davis JL
    J Gastrointest Oncol; 2019 Jun; 10(3):407-411. PubMed ID: 31183189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment.
    Luo W; Fedda F; Lynch P; Tan D
    Front Pharmacol; 2018; 9():1421. PubMed ID: 30568591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome.
    Kumar S; Long JM; Ginsberg GG; Katona BW
    World J Gastroenterol; 2019 Jun; 25(23):2878-2886. PubMed ID: 31249446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
    Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
    Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary diffuse gastric cancer: surgery, surveillance and unanswered questions.
    Cisco RM; Norton JA
    Future Oncol; 2008 Aug; 4(4):553-9. PubMed ID: 18684065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery.
    Cisco RM; Ford JM; Norton JA
    Cancer; 2008 Oct; 113(7 Suppl):1850-6. PubMed ID: 18798546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.